Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-03 Bozic Carmen EVP and CMO Sale 10b5-1 −5,651 $345.28 $2.0M 46,254
2023-10-02 Biller Jonathan EVP and Chief Legal Officer Sale 10b5-1 −610 $346.76 $212K 10,569
2023-09-29 Biller Jonathan EVP and Chief Legal Officer Shares withheld for taxes 10b5-1 −408 $350.72 $143K 11,179
2023-09-19 Bozic Carmen EVP and CMO Sale 10b5-1 −5,651 $351.00 $2.0M 51,905
2023-09-05 Bozic Carmen EVP and CMO Sale 10b5-1 −5,651 $352.66 $2.0M 57,556
2023-08-23 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −2,500 $355.00 $888K 48,637
2023-08-10 Kearney Terrence C Director Exercise or conversion 10b5-1 +10,000 $127.54 $1.3M 16,536
2023-08-10 Kearney Terrence C Director Sale 10b5-1 −10,000 $350.00 $3.5M 6,536
2023-08-10 Kearney Terrence C Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −10,000 10,000
2023-08-10 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −5,750 $345.79 $2.0M 51,137
2023-08-10 Sachdev Amit EVP, Chief Patient Officer Sale 10b5-1 −10,031 $350.00 $3.5M 58,814
2023-08-09 ALTSHULER DAVID EVP, Global Research and CSO Sale 10b5-1 −63 $345.51 $22K 32,038
2023-08-09 Bhatia Sangeeta N. Director Sale 10b5-1 −242 $345.51 $84K 4,386
2023-07-17 SACHS BRUCE I Director Exercise or conversion 10b5-1 +11,250 $127.54 $1.4M 51,250
2023-07-17 SACHS BRUCE I Director Sale 10b5-1 −1,697 $355.54 $603K 49,553
2023-07-17 SACHS BRUCE I Director Sale 10b5-1 −5,711 $356.75 $2.0M 43,842
2023-07-17 SACHS BRUCE I Director Sale 10b5-1 −3,842 $357.29 $1.4M 40,000
2023-07-17 SACHS BRUCE I Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −11,250 11,250
2023-07-17 Kewalramani Reshma CEO & President Sale 10b5-1 −7,828 $355.00 $2.8M 118,906
2023-07-14 SACHS BRUCE I Director Grant or award · Deferred Stock Units 10b5-1 +124.72 $350.79 $44K 14,524.97

Page 28 of 40 · 781 trades